AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Dr. Kimberley Forbes-McKean named SVP, chief technical science officer.

Pharma Business Week

| October 18, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Isolagen, Inc., (ILE) announced that its board of directors appointed Dr. Kimberley Forbes-McKean as senior vice president and chief technical science officer of Isolagen.

Forbes-McKean brings to Isolagen more than 15 years of experience in the pharmaceutical industry. She recently served as vice president of global dermatological product development and commercialization at Aventis global dermatology, a division of Aventis Pharmaceutical.

Frank DeLape, chairman of Isolagen, in commenting on the hire, said, "Dr. Forbes-McKean's broad experience in ...

Related articles from newspapers, magazines, journals, and more
Isolagen to Introduce ACE System at the UBS 2005 Global Pharmaceuticals...
Press release article from: PR Newswire May 19, 2005 700+ words
...May 19 /PRNewswire-FirstCall/ -- Isolagen, Inc. is scheduled to present at the...and Interim Chief Executive Officer of Isolagen will present a company overview, introduce Isolagen's design for a new automated closed loop...
Isolagen Acquires Additional Cell Processing Facility.
Newspaper article from: PR Newswire Europe April 6, 2005 700+ words
...Will Increase Capacity for Global Delivery of the Isolagen Process Isolagen, Inc. (Amex: ILE) announced today that it has...Africa and the Pacific Rim for the delivery of the Isolagen Process, will be operational by the end of 2006...
Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO).
Press release article from: PR Newswire January 8, 2008 700+ words
...Jan. 8 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. announced today that the...as Chief Financial Officer (CFO) of Isolagen Inc. for a period of time. Former Chief...Board of Directors and as a consultant to Isolagen, but has resigned as President and CEO...
Isolagen Fills Key Positions.
Press release article from: PR Newswire October 10, 2002 700+ words
Isolagen, Inc. (BULLETIN BOARD: ISLG) today...and Dr. Luke Lawson have joined the Isolagen team. Michael Macaluso, CEO, stated...and commitment to commercialization of Isolagen in the international markets, we believe...
Isolagen Process Initial Phase III Six Month Marker Data Positive.
Press release article from: PR Newswire July 28, 2004 700+ words
Isolagen, Inc. released six-month marker data of the first Isolagen Process Phase III study that indicates a positive response in 82% of the Isolagen treated patients who were evaluated. This initial and ongoing study was designed to assess...
Isolagen Opens Australian Cellular Facility.
Press release article from: PR Newswire January 23, 2003 700+ words
Isolagen, Inc. is proud to announce the opening...keeps us on schedule to commercialize the Isolagen autologous cellular therapy in multiple...markets of Korea and Hong Kong. The first Isolagen lab was opened in September 2002 in London...
Isolagen Announces Listing on The American Stock Exchange.
Press release article from: PR Newswire December 10, 2002 700+ words
Isolagen, Inc. (BULLETIN BOARD: ISLG) is pleased...American Stock Exchange (Amex). Trading of Isolagen's Common Stock will commence on the...December 11, 2002 under the symbol "ILE". Isolagen's Amex specialist will be Cohen Specialists...
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne...
Press release article from: PR Newswire March 14, 2008 700+ words
...March 14 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. announced today the completion...Study IT-A-008 investigating the Isolagen Therapy(TM) for the treatment of moderate...have now commenced. "We believe the Isolagen Therapy could hold great promise for...
Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen...
Press release article from: PR Newswire August 25, 2008 700+ words
...Aug. 25 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. announced today results...Phase II study (IT-R-007) of Isolagen Therapy(TM) for the treatment of facial...Study subjects received two treatments of Isolagen Therapy in multiple facial regions...
Isolagen and FDA Reach Agreement on Phase III Protocol Design.
Press release article from: PR Newswire October 13, 2006 700+ words
...Commence Pivotal Phase III Trials of Isolagen(TM) Therapy for the Treatment of Wrinkles...Oct. 13 /PRNewswire-FirstCall/ -- Isolagen, Inc. announced today that the Company...pivotal study protocol for the use of Isolagen(TM) Therapy for the treatment of wrinkles...
For more facts and information, see all results

Source: HighBeam Research, Dr. Kimberley Forbes-McKean named SVP, chief technical science...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA